# IDEXX Laboratories, Inc. (IDXX)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Market cap:** $45.19B  
**Price:** $557.69 (+0.13%)

> IDEXX Laboratories, Inc. is a healthcare diagnostics company specializing in products and services for the veterinary, livestock, poultry, dairy, and water testing markets. The company develops and manufactures diagnostic test kits, in-clinic analyzers, and reference laboratory services that support veterinarians in diagnosing and monitoring health conditions in companion animals. IDEXX Laboratories, Inc. also provides management software, digital imaging systems, and data analytics tools that help veterinary practices streamline workflows and clinical decision-making. Beyond companion animals, the company offers testing solutions for livestock and poultry health, dairy quality, and water microbiology, supporting food safety and public health monitoring. Its operations are organized into segments including Companion Animal Group, Water, Livestock, Poultry, and Dairy, and other related services. Founded in 1983 and headquartered in Westbrook, Maine, IDEXX Laboratories, Inc. plays a significant role in modern animal health diagnostics and environmental testing worldwide.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $4.30B | $2.66B | $1.36B | $1.06B | $13.08 |
| 2024 | $3.90B | $2.38B | $1.13B | $888M | $10.67 |
| 2023 | $3.66B | $2.19B | $1.10B | $845M | $10.06 |
| 2022 | $3.37B | $2.00B | $899M | $679M | $8.03 |
| 2021 | $3.22B | $1.89B | $932M | $745M | $8.60 |
| 2020 | $2.71B | $1.57B | $695M | $582M | $6.71 |
| 2019 | $2.41B | $1.37B | $553M | $428M | $4.89 |
| 2018 | $2.21B | $1.24B | $491M | $377M | $4.26 |
| 2017 | $1.97B | $1.10B | $413M | $263M | $2.94 |
| 2016 | $1.78B | $975M | $350M | $222M | $2.44 |
| 2015 | $1.60B | $890M | $300M | $192M | $2.05 |
| 2014 | $1.49B | $816M | $260M | $182M | $1.79 |
| 2013 | $1.38B | $756M | $267M | $188M | $1.74 |
| 2012 | $1.29B | $699M | $263M | $178M | $3.17 |
| 2011 | $1.22B | $647M | $236M | $162M | $2.78 |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $3.35B | $1.75B | $1.61B | $180M | $450M |
| 2024 | $3.29B | $1.70B | $1.60B | $288M | $618M |
| 2023 | $3.26B | $1.78B | $1.48B | $454M | $698M |
| 2022 | $2.75B | $2.14B | $609M | $113M | $770M |
| 2021 | $2.44B | $1.75B | $690M | $144M | $851M |
| 2020 | $2.29B | $1.66B | $632M | $384M | $909M |
| 2019 | $1.83B | $1.65B | $177M | $90M | $699M |
| 2018 | $1.54B | $1.55B | -$10M | $124M | $602M |
| 2017 | $1.71B | $1.77B | -$54M | $188M | $607M |
| 2016 | $1.53B | $1.64B | -$108M | $155M | $594M |
| 2015 | $1.47B | $1.56B | -$84M | $129M | $597M |
| 2014 | $1.38B | $1.27B | $118M | $323M | $350M |
| 2013 | $1.23B | $712M | $518M | $279M | $151M |
| 2012 | $1.10B | $467M | $636M | $224M | $3M |
| 2011 | $1.03B | $491M | $540M | $184M | $3M |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | $1.18B | $125M | $1.06B |
| 2024 | $929M | $121M | $808M |
| 2023 | $907M | $134M | $773M |
| 2022 | $543M | $149M | $394M |
| 2021 | $756M | $120M | $636M |
| 2020 | $648M | $107M | $541M |
| 2019 | $459M | $155M | $304M |
| 2018 | $400M | $116M | $284M |
| 2017 | $373M | $74M | $299M |
| 2014 | $236M | $61M | $175M |
| 2013 | $246M | $78M | $168M |
| 2012 | $222M | $58M | $165M |
| 2011 | $218M | $50M | $168M |
| 2010 | $179M | $39M | $140M |
| 2009 | $175M | $51M | $124M |

Source: [CompaniesByCap](https://companiesbycap.com/company/IDXX)